CD8+ T-cells play a major role in cellular responses, including in antitumor immune defense, while TILs contribute to good clinical outcomes in many types of cancer.[27] Muenst et al[28] found expression of PD-L1 was significantly associated with an increase in the number of TILs in breast cancer. The gene discussed is CD8A; the disease is breast cancer.